The Overlooked Choice - Invoking the Microbiome with an Evidence-Based Probiotic and Modeling its Financial Impact for Antibiotic-Associated Diarrhea including C. Difficile-Associated Diarrhea in Your Hospital 

Despite many attempts at the containment of C. diff infections in the hospital, it continues to exact a toll relative to patients’ lives and a significant economic burden to hospitals. 

The Boardroom Session is designed to obtain feedback on: 

The magnitude of the problem posed by C. diff 

The multi-disciplinary methods used to contain C. diff

How a probiotic may be another choice to manage C. diff 

Lastly, we would like to demonstrate a tool that will help model how a probiotic, when used with a comprehensive program to manage and mitigate C. diff infections, can improve patient outcomes, and substantially reduce the cost of containing and managing C. diff infections in your hospital.    

Click here to RSVP for i-Health's Boardroom Session.